Increased brain-derived neurotrophic factor following successful psychological treatment in generalized anxiety disorder: a randomized clinical trial
Overview
This randomized clinical trial examines changes in plasma brain-derived neurotrophic factor (BDNF) levels among patients with generalized anxiety disorder undergoing either group acceptance-based behavior therapy or supportive therapy over a 14-week period. The study measures BDNF concentrations before and after treatment to assess potential biological correlates of psychological intervention. Results indicate that BDNF levels increased significantly in both treatment groups, although no correlation was found between these changes and reductions in anxiety symptom severity.
- ID
6d7c5352c3314fc6- Source org
- PubMed Central
- Author
- Lucas Marques Gandarela (Faculdade São Lucas), Thiago P. de A. Sampaio (Universidade de São Paulo), Lia Marçal (Universidade de São Paulo), Emmanuel A. Burdmann (Universidade de São Paulo), Francisco Lotufo Neto (Universidade de São Paulo), Márcio Bernik (Universidade de São Paulo)
- Published
- 2026-04-07
- OA status
- gold
- DOI
- 10.1186/s12888-026-08027-8
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- 0
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 0.95 · checked_at unknown
- linkok via http-check · 2026-07-21T15:52:31.592259+00:00
Cite this entry
BibTeX
@article{allodium:6d7c5352c3314fc6,
title = {Increased brain-derived neurotrophic factor following successful psychological treatment in generalized anxiety disorder: a randomized clinical trial},
author = {Lucas Marques Gandarela and Thiago P. de A. Sampaio and Lia Marçal and Emmanuel A. Burdmann and Francisco Lotufo Neto and Márcio Bernik},
year = {2026},
journal = {PubMed Central},
doi = {10.1186/s12888-026-08027-8},
url = {https://doi.org/10.1186/s12888-026-08027-8}
}RIS
TY - JOUR TI - Increased brain-derived neurotrophic factor following successful psychological treatment in generalized anxiety disorder: a randomized clinical trial AU - Gandarela, Lucas Marques AU - Sampaio, Thiago P. de A. AU - Marçal, Lia AU - Burdmann, Emmanuel A. AU - Neto, Francisco Lotufo AU - Bernik, Márcio PY - 2026 PB - PubMed Central DO - 10.1186/s12888-026-08027-8 UR - https://doi.org/10.1186/s12888-026-08027-8 ER -
APA
Gandarela, L. M., Sampaio, T. P. D. A., Marçal, L., Burdmann, E. A., Neto, F. L., & Bernik, M. (2026). Increased brain-derived neurotrophic factor following successful psychological treatment in generalized anxiety disorder: a randomized clinical trial. PubMed Central. https://doi.org/10.1186/s12888-026-08027-8
Related entries
- Short-Term Psychodynamic Psychotherapy and Cognitive-Behavioral Therapy in Generalized Anxiety Disorder: A Randomized, Controlled Trial
- Efficacy of an acceptance-based behavior therapy for generalized anxiety disorder: Evaluation in a randomized controlled trial.
- Neuroplasticity in response to cognitive behavior therapy for social anxiety disorder
- Inflammatory markers changes following acceptance-based behavioral psychotherapy in generalized anxiety disorder patients: Evidence from a randomized controlled trial
- Mindfulness-based cognitive therapy <i>v.</i> group psychoeducation for people with generalised anxiety disorder: Randomised controlled trial
- Telephone-Delivered Cognitive Behavioral Therapy and Telephone-Delivered Nondirective Supportive Therapy for Rural Older Adults With Generalized Anxiety Disorder
- Psychotherapies for generalized anxiety disorder in adults: systematic review and network meta-analysis of randomized-controlled trials
- Effectiveness of mindfulness‐based cognitive therapy in patients with anxiety disorders in secondary‐care settings: A randomized controlled trial
- Effect of Acceptance-Based Behavior Therapy on Severity of Symptoms, Worry and Quality of Life in Women With Generalized Anxiety Disorder
- Cognitive-behavioral therapy for generalized anxiety